Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Novavax Inc (NVAX)

Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Novavax Announces Entering into a License Agreement with Pfizer

GAITHERSBURG, Md. , Jan. 20, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) has entered into a license agreement with Pfizer for use of Novavax's Matrix-M ® adjuvant. Under the terms of...

NVAX : 8.20 (+2.37%)
2 Growth Stocks with Explosive Upside and 1 That Underwhelm

2 Growth Stocks with Explosive Upside and 1 That Underwhelm

NFLX : 87.26 (-0.84%)
TTMI : 97.83 (-3.15%)
NVAX : 8.20 (+2.37%)
Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference

GAITHERSBURG, Md. , Jan. 7, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the 44 th Annual J.P. Morgan Healthcare Conference.

NVAX : 8.20 (+2.37%)
Q3 Earnings Outperformers: Novavax (NASDAQ:NVAX) And The Rest Of The Therapeutics Stocks

Q3 Earnings Outperformers: Novavax (NASDAQ:NVAX) And The Rest Of The Therapeutics Stocks

NVAX : 8.20 (+2.37%)
Novavax (NVAX) Stock Trades Up, Here Is Why

Novavax (NVAX) Stock Trades Up, Here Is Why

NVAX : 8.20 (+2.37%)
Novavax (NASDAQ:NVAX) Surprises With Q3 CY2025 Sales

Novavax (NASDAQ:NVAX) Surprises With Q3 CY2025 Sales

NVAX : 8.20 (+2.37%)
Novavax to Participate in Jefferies London Healthcare Conference

GAITHERSBURG, Md. , Nov. 12, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the following upcoming investor conference:

NVAX : 8.20 (+2.37%)
Novavax: Q3 Earnings Snapshot

Novavax: Q3 Earnings Snapshot

NVAX : 8.20 (+2.37%)
Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights

GAITHERSBURG, Md. , Nov. 6, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the third quarter ended September 30, 2025.

NVAX : 8.20 (+2.37%)
Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovidâ„¢, Triggering a $25 Million Milestone Payment

GAITHERSBURG, Md. , Nov. 4, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) has completed the transfer of the U.S. marketing authorization for its COVID-19 vaccine, Nuvaxovid™ to Sanofi, enabling...

NVAX : 8.20 (+2.37%)

Barchart Exclusives

Trump’s Greenland Threats Scaring You Off? Buy This Dividend Stock as a Hedge
Trump's threats to seize Greenland have led to a selloff in risk assets while precious metals have rallied amid the flight to safe-haven assets. Agnico-Eagle Mines is a good dividend stock to buy amid the geopolitical turmoil. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar